Cymbalta Recall 2024 Fda

Cymbalta Recall 2024 Fda. Duloxetine (marketed as cymbalta) is included in the class of drugs called selective serotonin/norepinephrine reuptake inhibitors (snris). The fda issued a recall notice for more than 7,000 bottles of duloxetine, a drug used to treat depression, anxiety, and nerve pain.

Over 7,000 bottles of the antidepressant medication duloxetine, sold under the brand name cymbalta, have been. The recall involves the medication duloxetine, which is sold under the brand name cymbalta, according to the fda’s notice of the voluntary recall, which began oct.